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Abstract
Background: To investigate whether there are bi-directional associations between anxiety and mood disorders and
body mass index (BMI) in a cohort of young adults.
Methods: We analysed data from the 2004–2006 (baseline) and 2009–2011 (follow-up) waves of the Childhood
Determinants of Adult Health study. Lifetime DSM-IV anxiety and mood disorders were retrospectively diagnosed
with the Composite International Diagnostic Interview. Potential mediators were individually added to the base
models to assess their potential role as a mediator of the associations.
Results: In males, presence of mood disorder history at baseline was positively associated with BMI gain (β = 0.77,
95% CI: 0.14–1.40), but baseline BMI was not associated with subsequent risk of mood disorder. Further adjustment
for covariates, including dietary pattern, physical activity, and smoking reduced the coefficient (β) to 0.70 (95% CI:
0.01–1.39), suggesting that the increase in BMI was partly mediated by these factors. In females, presence of mood
disorder history at baseline was not associated with subsequent weight gain, however, BMI at baseline was associated
with higher risk of episode of mood disorder (RR per kg/m2: 1.04, 95% CI: 1.01–1.08), which was strengthened (RR per
kg/m2 = 1.07, 95% CI: 1.00–1.15) after additional adjustment in the full model. There was no significant association
between anxiety and change in BMI and vice-versa.
Conclusion: The results do not suggest bidirectional associations between anxiety and mood disorders, and
change in BMI. Interventions promoting healthy lifestyle could contribute to reducing increase in BMI
associated with mood disorder in males, and excess risk of mood disorder associated with BMI in females.
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Background
Mental disorders, including mood disorders and anxiety
disorders, and obesity or overweight are very prevalent
and associated with many other diseases. Globally, the
prevalence of overweight or obesity exceeds 37% among
adults aged 18 years and over, and has tripled over the
last four decades [1]. The global lifetime prevalence of
mood disorder and anxiety disorders is estimated to be
13 and 10%, respectively [2]. The number of people af-
fected by mood disorders and anxiety has also increased
worldwide by 18% and by 15%, respectively between
2005 and 2015 [3]. Mental disorders and overweight or
obesity are frequently co-occurring conditions [4, 5], and
share common risk factors such as lower socioeconomic
status, physical inactivity, smoking, and alcohol consump-
tion [6, 7]. These conditions have shared consequences,
including increased risk of morbidity and mortality from
several diseases such as cardiovascular diseases, type 2
diabetes, and certain types of cancer [8–11].
Depressive-anxiety disorders may contribute to weight
gain through their association with poor eating habits,
physical inactivity, and poor adherence to recommended
lifestyle modifications, which could influence future
changes in adiposity [6, 12, 13]. On the other hand, social
stigma associated with excess weight or obesity may have a
negative impact on body image, self-esteem, and social in-
teractions that are related to the development of
depressive-anxiety disorders [12, 13]. Medications used to
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treat several mental disorders are known to cause weight
gain [14]. The link between depressive-anxiety disorders
and change in body weight may also be confounded or me-
diated by several variables including age, gender and socio-
economic status [13, 15, 16]. Previous studies have shown
that inflammation is associated with both weight change
and mental health disorders, although the associations vary
based on adjusting for confounders and on how inflamma-
tion and mental health disorders were measured [17–19].
Evidence also noted sex difference in the association be-
tween BMI and depression, and suggested for sex-specific
analyses of both BMI and anxiety or depression [20]. Stud-
ies with consideration of a wide range of potential con-
founding or mediating variables are of use as they can help
our understanding of the mechanisms for the associations
and inform prevention and treatment strategies.
Mood disorders and anxiety, and weight gain are closely
related and recognized as common conditions among ado-
lescents and young adults [1, 7]. Most of the studies exam-
ining the link between depressive and anxiety disorders and
body weight are cross-sectional, making it difficult to dis-
cern the temporal relationship of these conditions. Longitu-
dinal studies that examined the direction of the association
between depressive-anxiety disorders and change in body
weight have mixed findings; with meta-analyses and large
cohort studies showing that some [21–23], but not all stud-
ies [15, 24, 25] report bidirectional associations between
these conditions. Evidence of temporal sequences mood
disorders and anxiety, and weight change among young
adults can help to optimize the prevention, early detection,
and treatment services for both disorders. This study inves-
tigated whether there are bi-directional associations be-
tween anxiety and mood disorders, and BMI change in a
prospective cohort of young adults.
Methods
Study design and participants
The present study analysed data from the Childhood
Determinants of Adult Health (CDAH) study. Details of
the study design and participants were previously reported
[26, 27]. In brief, the CDAH study started with the follow-
up of 8498 schoolchildren (7–15 years) who participated
in the 1985 Australian Schools Health and Fitness Survey
(ASHFS) [27]. The CDAH study was set up to investigate
the contribution of childhood factors to the risk of devel-
oping cardiovascular diseases in later life [27]. At baseline
(2004–2006), and at follow-up (2009–2011) participants
completed assessments of mood disorder, anxiety disor-
ders and their lifestyle behaviours. The present study in-
cluded 11,638 participants who have complete anxiety and
BMI data at baseline and at follow-up, and 1646 who have
complete baseline and follow-up data on BMI and mood
disorder (Fig. 1) [28]. Participants were 26–36 years at
baseline and 31–41 years at follow-up.
Covariates
At baseline and follow-up, participants reported recent
sociodemographic information, including occupation, edu-
cation, and marital status. Details of the baseline and follow-
up measurements and procedures have been described
previously [26, 28]. Family history of cardiometabolic disease
(myocardial infarction, stroke, high blood pressure, coronary
heart disease and diabetes), lifestyle behaviours and risk
factors, including smoking, and alcohol consumption were
recorded using self-administered questionnaire [26].
When completing the Food Frequency and Habits
questionnaire, participants were asked to refer to their
diet during the 12months prior to the interview. The
combined Dietary Guideline Index (DGI) was used to
generate a dietary score. It assesses adherence to the
Dietary Guidelines for Australian Adults and covers con-
sumption of foods from the core food groups, along with
other items such as use of salt and fluid intake. The DGI
includes 15 items that are scored using 127 items from a
food frequency questionnaire [12]. Higher scores indi-
cated closer adherence to dietary guidelines. The Inter-
national Physical Activity Questionnaire (IPAQ) was
used to assess the duration of moderate- and vigorous-
intensity leisure, work, active commuting, and yard or
household physical activity in the past week. Total phys-
ical activity is calculated by summing all four domain
sub-scores according to the IPAQ scoring protocol [29].
Residential postcode was used to derive area-level
socio-economic status based on the Australian Bureau of
Statistics Postal Area Index of Relative Socio-Economic
Disadvantage. The Henderson Interview Schedule for
Social Interaction (ISSI) asks respondents about the
number of people with whom they share strong affectual
attachments and about the perceived adequacy of these
relationships were used to derive a Social Support Index
(SSI) [30]. We used the NEO Five-Factor Inventory
(NEO-FFI) to assess the personality (Neuroticism, Extra-
version, Openness to Experience, Agreeableness, and
Conscientiousness) of the participants [31, 32].
Serum C-reactive protein (CRP) at baseline was mea-
sured from fasting venous blood samples using an auto-
mated analyser and a highly sensitive turbidimetric
immunoassay kit. Fasting plasma glucose was measured
enzymatically with the Olympus AU5400 automated
analyser. Blood pressure was measured at follow-up
using a digital automatic monitor.
At baseline, BMI was calculated as weight divided by the
square of height. For those with self-reported height and
weight data, a correction factor was applied based on a
validation study from the same cohort [33]. At follow-up,
all participants reported their BMI, and therefore the cor-
rection factor applied to all BMI. We classified persons
into three BMI categories: Normal weight (18.50–24.99),
overweight (25 ≤ BMI ≤ 29.99) and obese (BMI ≥ 30).
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Assessment of anxiety and mood disorders
At follow-up, lifetime history of DSM-IV disorder were
obtained from the Composite International Diagnostic
Interview (CIDI-Auto 2.1 version) via telephone inter-
view with trained interviewers [26].
“Presence of mood disorder history at baseline” was de-
fined as an episode of depression/dysthymia that occurred
prior to baseline; and “presence of anxiety history at base-
line” as an episode of anxiety that occurred prior to base-
line. We categorized those with a diagnosis of mood
disorders, or anxiety disorder between baseline and
CDAH2 as having ‘episode’ (first or recurrent events) of
these disorders, or having ‘first episode’ in those without
history mood or anxiety disorders who suffered from these
disorders for the first time since baseline.
Statistical analyses
History mood and anxiety disorder predicting BMI change
We used linear regression models to estimate the associ-
ation of history of mood disorders before baseline and BMI
change measured as body mass index (BMI) at follow-up
adjusted for potential confounders including BMI at base-
line. This method, sometimes known as repeated measures
analysis of covariance, is a preferred method for analyses of
longitudinal changes with only two time-points [34, 35].
We used the same approach to examine if history of anxiety
disorder predicted subsequent BMI change.
BMI at baseline predicting mood and anxiety disorders
We used log-binomial regressions to estimate the rela-
tive risks (RR) ± 95% confidence interval (CI) of baseline
BMI (per 1 kg/m2) on mood and anxiety disorders diag-
nosed since baseline, while adjusting for potential con-
founders. Sensitivity analyses were conducted by limiting
these associations to those who had an episode of mood
and anxiety disorder diagnosed in the 12months prior
to CDAH2. Approaches to the data analyses and vari-
ables included in the base model are given in the
Additional file 1. Both analyses were stratified by sex
because of presumed differences in the relationship
between BMI and mental health disorders.
In the base model, the associations were adjusted for po-
tential confounders, including age, history of cardiometa-
bolic conditions, social support and duration of follow-up.
Other covariates including C-reactive protein, antidepres-
sant use, dietary pattern and lifestyle factors were serially
added to the base models to test their potential role as a
mediator of the associations. In the linear regression
models, the mediation effect was calculated as the differ-
ence between the total effect (base model without medi-
ator) and the direct effect (base model with mediator) [36].
In the log-binomial regressions models, the percentage of
excess risk explained by the mediator (PERM) was esti-
mated as a ratio of the difference between the unadjusted
(total effect) and the adjusted (direct effect) relative risks,
and the unadjusted excess risk (total effect) [37], as:
PERM ¼ Confounder adjusted RR−Confounder and mediator adjusted RRConfounder adjusted RR−1 100:
Follow-up and handling of missing data
For the current study, 3965 participants completed ques-
tionnaires at baseline about their health behaviours and
outcomes, including those who undertook physical mea-
sures of the cardiovascular health in clinics (n = 2385).
At follow-up, 2815 of the eligible sample at baseline
completed questionnaires. Out of these, 1646 partici-
pants (n = 1012 females) who had complete data on BMI
Fig. 1 Participation flow chart
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and presence of mood disorder history at baseline and at
follow-up were included in the analyses of mood dis-
order and BMI change and vice-versa. The analyses on
anxiety and BMI change included 1638 participants
(1008 females) who had complete data for those vari-
ables at baseline and at follow-up and vice-versa.
For the sample with complete outcome and predictor
data as described above, we imputed any missing values
of covariates using multiple imputation by chained equa-
tions (with 50 estimates). Variables recorded at the ori-
ginal childhood study as well as baseline and follow-up
that predicted probability of response were included in
the missingness model, including sociodemographics, fit-
ness and health behaviours. We used inverse probability
weights for addressing loss from the original ASHFS
random sample to the analysis sample. Any observations
required for the weights model that were missing were
imputed using the imputed datasets, so that a complete
set of weights for the analysis sample was available. For
each of the fifty imputed datasets a set of weights was
derived and applied to the analysis model. The resulting
fifty different model estimates were combined using
Rubin’s rules to get an average point estimate and stand-
ard error that reflects variation in the weights and im-
puted covariates, as well as the individual estimates.
Results
Table 1 presents a summary of participant characteris-
tics. In general, about half of the participants were from
low or medium to low socioeconomic status, and nearly
half had tertiary education at follow-up. History of heart
diseases or diabetes was reported by 16% of males and
10% of females. History of mood and anxiety disorder
were nearly twice as common in females as males both
at baseline and at follow-up.
History of mood disorder and anxiety predicting BMI
change
Of the total 634 males and 1012 females who have
complete data for BMI and presence of mood disorder
history at baseline and at follow-up, 85 (13.4%) males
and 229 (22.6%) females had a history of mood disorder
at baseline. In males, after adjustment for covariates in
the base model, including age, education, family history
of cardiometabolic diseases and social support score, his-
tory of mood disorder at baseline was associated with an
increase in BMI (β = 0.77, 95% CI: 0.14–1.40, P = 0.017).
Serial adjustment for potential mediators, including
smoking status, adherence to DGI, moderate-to-vigorous
physical activity reduced the average BMI increase due
to history of mood disorder to 0.70 (β = 0.70, 95% CI:
0.01–1.39). This suggests that 0.07 kg/m2 of the average
increase in BMI is mediated by these factors. However,
antidepressant use has no effect on the association
between history of mood disorder and BMI change (β =
0.77, 95% CI: 0.05–1.49). In males, extra food consump-
tion, moderate or vigorous physical activity, dietary ad-
herence and smoking status appeared to be the strongest
mediators (Table 2).
Among females, a history of mood disorder was asso-
ciated with a smaller increase in BMI (β = 0.53, 95% CI:
0.00–1.06, p = 0.048), which was attenuated (β = 0.39,
95% CI: − 0.16-0.95) after further adjustment for partici-
pants health behaviours. The full list of the effect of indi-
vidual covariates on the associations between history of
mood disorder and BMI change in males and females is
presented in Table 2.
In the base model, history of anxiety was associated
with a non-significant increase in BMI in males (β =
0.16, 95% CI: − 0.45-0.76) and females (β = 0.01, 95% CI:
− 0.59-0.61). Further adjustment for potential mediators,
including C-reactive protein, antidepressant use, physical
activity, diet and smoking did not significantly change
the associations between history of anxiety and BMI
change in both males (β = 0.19, 95% CI: − 0.44-0.62) and
females (β = 0.16, 95% CI: − 0.48-0.80). The results are
presented as Additional file 2.
Baseline BMI predicting mood and anxiety disorders
In females (RR per kg/m2: 1.04, 95% CI: 1.01–1.08), BMI
at baseline tended to increase the risk of episode of
mood disorder between baseline and follow-up, and
mood disorder diagnosed in the 12months prior to
CDAH2 (RR per kg/m2: 1.03, 95% CI: 1.00–1.07). Serial
adjustment strengthened both the risk of mood disorder
(RR per kg/m2: 1.07, 95% CI: 1.00–1.15) and risk of
mood disorder diagnosed in the 12months prior to
CDAH2 (RR per kg/m2: 1.06, 95% CI: 1.00–1.13)
(Table 3).
In males, BMI at baseline did not predict the risk of
mood disorder (RR per kg/m2: 0.97, 95% CI: 0.90–1.04),
or mood disorder diagnosed in the 12months prior to
CDAH2 (RR per kg/m2: 0.94, 95% CI: 0.86, 1.03) in
males. These findings persisted after adjustment for po-
tential mediators including health behaviours, diet and
physical activity. In females, adjusting for body weight
satisfaction increased the risk of an episode of mood dis-
order (RR per kg/m2: 1.08 95% CI: 1.00–1.16) but not
mood disorder diagnosed in the 12months prior to
CDAH2 (RR per kg/m2: 1.11 (0.94–1.30). In males, body
weight satisfaction was not associated with episode of
mood disorder or mood disorder diagnosed in the 12
months prior to CDAH2 (Table 3).
After adjusting for confounding factors in the base
model, BMI at baseline did not significantly predict epi-
sode of anxiety in males (RR per kg/m2: 0.96, 95% CI:
0.87–1.07) or females (RR per kg/m2: 0.99, 95% CI:
0.94–1.04). Further adjustment for potential mediators,
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Table 1 Characteristics of the study participants included in the analyses
Variables Mood disorder before baseline
predicting BMI (n = 1646) #
Anxiety before baseline predicting
BMI (n = 1638) #
Men (n = 634) Women (n = 1012) Men (n = 630) Women (n = 1008)
Age, years 31.9 ± 2.6 31.6 ± 2.7 31.9 ± 2.6 31.6 ± 2.7
Education
Tertiary 282 (44.7) 520 (51.8) 280 (44.7) 517 (51.8)
Vocational 235 (37.2) 269 (26.8) 234 (37.3) 268 (26.8)
School only 114 (18.1) 214 (21.3) 113 (18.0) 214 (21.4)
Socio-economic quartile
High 742 (23.2) 748 (24.1) 134 (26.2) 211 (27.1)
Med-high 914 (28.6) 886 (28.6) 141 ()27.6 209 (26.9)
Med-low 1230 (38.5) 1197 (38.6) 196 (38.4) 314 (40.4)
Low 310 (9.7) 272 (8.8) 40 (7.8) 44 (5.7)
Smoking
Never 385 (61.0) 582 (57.6) 384 (61.2) 580 (57.6)
Former 141 (22.4) 295 (29.2) 140 (22.3) 294 (29.2)
Current 105 (16.6) 134 (13.2) 103 (16.4) 133 (13.2)
Change in marital status since baseline
Never married 160 (14.1) 179 (11.5) 75 (13.0) 116 (12.5)
Become married/defacto 179 (15.7) 170 (10.9) 99 (17.2) 75 (8.1)
Stayed married 741 (65.1) 1097 (70.4) 381 (66.0) 674 (72.7)
Became divorced/widowed 32 (2.8) 56 (3.6) 10 (1.7) 29 (3.1)
Stayed separated/widowed 8 (0.7) 24 (1.5) 4 (0.7) 13 (1.4)
Parental status since baseline
No children 436 (34.60) 484 (28.2) 206 (40.0) 265 (27.2)
First child born 315 (25.0) 326 (19.0) 164 (27.1) 185 (19.0)
Additional children born 235 (18.7) 359 (20.9) 110 (18.2) 214 (22.0)
Same number of children 274 (21.8) 548 (31.9) 126 (20.8) 311 (31.9)
Body mass index (kg/m2) 26.6+ 4.4 25.5 ± 5.7 26.6 ± 4.5 25.5 ± 5.7
History of CVD or diabetes 83 (16.0) 83(9.9) 83 (16.1) 83 (10.0)
Social support index N = 543, 61.2 ± 8.0 N = 872, 62.5 ± 7.1 61.3 ± 8.0 62.6 ± 7.1
Total healthy lifestyle score 2.2 ± 1.8 2.2 ± 1.7
SF-12 physical component score 53.7 ± 6.4 53.2 ± 7.6 53.7 ± 7.5 53.3 ± 7.5
Total diet score 99.7 ± 19.1 107.9 ± 17.4 99.8 ± 19.2 107.8 ± 17.4
Anxiety before baseline 77 (12.0) 210 (19.1) 76 (12.1) 195 (19.4)
Mood disorder before baseline 85 (13.4) 229 (22.6) 85 (13.5) 226 (22.4)
Lifetime depression (at CDAH2)
Never 521 (82.2) 710 (70.2) 532 (84.4) 751 (74.5)
History 30 (4.7) 102 (10.1) 16 (2.5) 27 (2.7)
Recurrent 55 (8.7) 127 (12.6) 60 (9.5) 168 (16.7)
Incident 28 (4.4) 73 (7.2) 22 (3.5) 62 (6.5)
Mood disorder 12 months prior to CDAH2 (incident and recurrent) 40 (6.3) 92 (9.1) 40 (6.3) 91 (9.0)
Lifetime anxiety (at CDAH2)
Never 532 (84.4) 751(74.5) 517(82.1) 709 (70.3)
History 16 (2.5) 27 (2.7) 30 (4.8) 100 (9.9)
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including body weight satisfaction, did not significantly
change the associations between baseline BMI and epi-
sode of anxiety in both males (RR per kg/m2: 1.07,
95%CI: 0.76–1.50) and females (RR per kg/m2: 1.00,
95%CI: 0.93–1.09). The finding of no significant associ-
ation between baseline BMI and episode of anxiety did
not change when the analyses was limited to those diag-
nosed with anxiety in the previous 12months of the
CDAH2 in both males and females. The results are pre-
sented as Additional file 3.
Discussion
This study of a cohort of young adults did not find a
bidirectional relationship between anxiety and mood dis-
orders and BMI. A history of mood disorder was signifi-
cantly associated with an increase in BMI in males,
while higher BMI at baseline was related to higher risk
of mood disorders in females. These associations were
mediated by dietary pattern and lifestyle factors, suggest-
ing that health behaviour interventions may promote
both physical and mental wellbeing. There was no signifi-
cant association between history of anxiety and subsequent
change in BMI or vice versa in both males and females.
Association between BMI and mood disorder
This study adds to the relatively small number of pro-
spective studies examining the temporal relationship
between mood and anxiety disorders and change in BMI
while controlling for the mediation effects of a wide
range of variables. It is one of few studies to examine the
effect of a wide range of potential confounding or medi-
ating variables on these associations. While a bidirec-
tional association between anxiety and BMI change is
rarely reported, evidence regarding bidirectional associ-
ation between mood disorder and BMI change is incon-
sistent [23, 24, 38]. There are several possible reasons
for the inconsistent results among the studies including
variation in the populations studied in terms of age at
onset, duration of episodes, duration of study follow-up,
method of mental disorder assessment, and severity of
these disorders [21, 39, 40]. Recent evidence suggest that
the unfavourable effect of depression on development of
weight gain and the effect of weight gain on develop-
ment of depression may be reinforced by follow-up time,
suggesting that the associations between these disorders
may be less apparent in studies with short follow-up
[21]. Mood disorders with onset at younger ages tend to
have a more unfavourable course and are associated with
greater comorbidity than those with a late-onset [39].
Previous studies have also shown that younger adults are
more likely to seek care for their mental illness, reducing
the duration of an episode and recurrence rates [40–42],
onset of mood disorder-related unhealthy lifestyle and
comorbid conditions [40, 42].
The positive association between history of mood dis-
order and subsequent increase in BMI in males is con-
sistent with the findings of some studies [43, 44]. The
increase in BMI among males attributed to mood dis-
order is relatively small, although it could be a clinically
significant increase in light of the wide range of adverse
health effects with even a small increase in BMI above
the normal range. For example, a one- kg/m2 increase in
BMI raises heart failure risk by 17% [45], and type 2 dia-
betes by 15 and 11% in men and women, respectively,
independent of subsequent weight changes [46].
There could be several explanations for our findings that
the association between history of disorder and BMI was
weaker in females than in males. Firstly, the statistical
power to detect association is reduced due to variation in-
troduced when applying methods to address large scale at-
trition in this cohort. The effect size estimate for females
is smaller than that for males. This might be explained by
the fact that females are more likely to report mental
health disorders and seek mental health services [41],
which may improve their quality of life and response to
mood disorders [47]. According to the 2007 Australian
health survey, more women (41%) with a 12-month men-
tal disorder accessed services for mental health problems
than men (28%) [48]. In the UK, more than 750,000
people were referred for counselling for anxiety and de-
pression in 2012–2013, of whom 62% were women [41].
Women also tend to have a better coping strategies and
favourable outcomes than men, which could possibly at-
tenuate the potential BMI increase among women with
history of mood disorder [49, 50]. In addition, evidence
shows that depression-related unhealthy lifestyles, which
in turn could lead to BMI change, are more common in
males than in females [51].
Table 1 Characteristics of the study participants included in the analyses (Continued)
Variables Mood disorder before baseline
predicting BMI (n = 1646) #
Anxiety before baseline predicting
BMI (n = 1638) #
Men (n = 634) Women (n = 1012) Men (n = 630) Women (n = 1008)
Recurrent 60 (9.5) 168 (16.7) 55 (8.7) 126 (12.5)
Incident 22 (3.5) 62 (6.2) 28 (4.4) 73 (7.2)
Anxiety 12months prior to CDAH2 (incident and recurrent) 47 (7.5) 141 (14.0) 47 (8.1) 141 (15.8)
N (%) Mean ± standard deviation, CDAH Childhood Determinants of Adult Health, CVD Cardiovascular diseases (Myocardial infarction, stroke, coronary heart
disease, high blood pressure), SF-12 Short Form 12, a health-related quality of life instrument
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Table 2 Association between history of mood disorders before baseline and BMI at follow-up
Variables β (95% CI) after inclusion of potential mediators or confoundersa Total mediated effect
Males
Baseline measurements
Base model 0.77 (0.14–1.40) –
C-reactive protein 0.67 (−0.02–1.37) 0.10
Moderate or vigorous physical activity 0.85 (0.14–1.56) −0.08
Steps per day 0.72 (0.03–1.42) 0.05
Dietary adherence 0.70 (0.01–1.39) 0.07
Dietary guideline index 0.71 (0.02–1.4) 0.06
Extra food consumption 0.88 (0.11–1.64) −0.11
Takeaway food consumption 0.70 (0.01–1.39) 0.07
Antidepressant use 0.77 (0.05–1.49) 0
Smoking status 0.70 (0.02–1.38) 0.07
Additional follow-up variables
Moderate or vigorous physical activity 0.70 (0.00–1.40) 0.07
Steps per day 0.68 (−0.01–1.40) 0.09
Dietary guideline index 0.71 (0.01–1.40) 0.06
Dietary adherence 0.71 (0.02–1.40) 0.06
Change between baseline and follow-up
Change in steps per day 0.68 (−0.02–1.38) 0.09
Change in smoking status 0.72 (0.04–1.39) 0.05
Change in dietary Guideline Index 0.70 (0.01–1.39) 0.07
Full model 0.70 (0.01–1.39) 0.07
Females
Baseline measurements
Base model 0.53 (0.00,1.06) –
C-reactive protein 0.41 (−0.14,0.96) 0.12
Moderate or vigorous physical activity 0.41 (−0.15,0.96) 0.12
Steps per day 0.41 (−0.14,0.97) 0.12
Dietary adherence 0.40 (−0.15,0.95) 0.13
Dietary Guideline Index 0.40 (−0.15,0.95) 0.13
Extra food consumption 0.59 (0.02,1.16) −0.06
Takeaway food consumption 0.41 (−0.14,0.96) 0.12
Antidepressant use 0.46 (−0.16,1.07) 0.07
Smoking status 0.39 (−0.17,0.95) 0.14
Additional follow-up variables
Moderate or vigorous physical activity 0.40 (−0.15,0.95) 0.13
Steps per day 0.34 (−0.21,0.90) 0.19
Dietary Guideline Index 0.40 (−0.15,0.95) 0.13
Dietary adherence 0.40 (−0.15,0.96) 0.13
Change between baseline and follow-up
Change in steps per day 0.39 (−0.16,0.94) 0.14
Change in smoking status 0.44 (−0.11,0.99) 0.09
Change in dietary Guideline Index 0.39 (−0.16,0.95) 0.14
Full model 0.39 (−0.16,0.95) 0.14
Base model includes: Baseline BMI (kg/m2), age, education, duration of follow-up, history of cardiometabolic disease, Social Support index, physical
activity, self-reported physical health status and extraversion
aCovariates, associated with mood disorder based on a univariate models (at p < 0.1) were added one at a time to the base model to test for mediating
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Table 3 Effect of potential confounders or mediators on the associations between BMI at baseline and episode of mood disorder
Variables Episode of mood disorder since baseline
(vs. those with no history)
PERM Episode of mood disorder 12 leading to CDAH2
(vs those with no history)
PERM
Adjusted RR (95% CI) after inclusion
of covariate
Adjusted RR (95% CI) after inclusion of covariate
Males
Base model 0.97 (0.90,1.04) 0.94 (0.86,1.03) –
C-reactive protein 0.94 (0.82,1.08) −100 0.92 (0.84,1.02) −33.3
Dietary guideline index 0.95 (0.87,1.03) −66.7 0.94 (0.85,1.03) 0
Antidepressant use 0.92 (0.83,1.03) − 166.7 0.94 (0.85,1.04) 0
Smoking status 0.94 (0.86,1.03) 100 0.94 (0.85,1.04) 0
Fibrinogen 0.91 (0.88,1.06) 200 0.94 (0.85,1.04) 0
Moderate or vigorous physical
activity
0.88 (0.68,1.12) 300 0.88 (0.72,1.07) −100
Steps per day 0.89 (0.69,1.15) − 266.7 0.88 (0.72,1.08) −100
Extra food consumption 0.94 (0.83,1.07) −100 0.94 (0.85,1.04) 0
Smoking status at follow-up 0.92 (0.81–1.06) −166.7 0.87 (0.72,1.07) −
116.7
Moderate or vigorous physical
activity
0.88 (0.64,1.20) 300 0.86 (0.70,1.06) −
133.3
Dietary guideline index 0.94 (0.80–1.09) −100 0.93 (8.83–1.04) −16.7
Weight satisfaction 0.90 (0.76,1.08) − 233.0 0.92 (0.80,1.07) −33.3
Dietary adherence 0.86 (0.61,1.21) − 366.0 0.87 (0.70,1.09) −116.7
Takeaway food consumption 0.93 (0.78,1.11) −133.3 0.93 (0.83,1.04) −16.7
Full model 0.93 (0.78,1.11) −133.3 0.93 (0.83,1.04) −16.7
Females
Base model 1.04 (1.01,1.08) 1.03 (1.00,1.07) –
C-reactive protein 1.09 (1.01,1.17) − 125.0 1.06 (1.03,1.11) −100
Dietary guideline index 1.05 (1.00,1.11) −25.0 1.06 (1.02,1.10) −100
Antidepressant use 1.06 (0.99,1.14) −50.0 1.07 (1.02,1.12) −133.3
Smoking status 1.07 (1.02,1.13) −75.0 1.06 (1.02,1.10) −100
Fibrinogen 1.13 (0.98–1.30) − 225 1.06 (1.01–1.11) − 100
Moderate or vigorous physical
activity
1.13 (0.98,1.30) −225 1.12 (1.02,1.23) − 300
Steps per day 1.15 (0.99,1.33) 275 1.13 (1.00,1.28) −
333.3
Extra food consumption 1.07 (1.00,1.15) −75.0 1.06 (1.00,1.13) −100
Smoking status at follow-up 1.06 (0.99–1.14) −50.0 1.12 (1.02,1.23) −300
Moderate or vigorous physical
activity at follow-up
1.06 (0.99,1.14) −50.0 1.06 (1.01,1.11) −100
Dietary guideline index at
follow-up
1.13 (0.98–1.30) −225.0 1.13 (1.02–1.24) −333.3
Weight satisfaction 1.08 (1.00,1.16) −100 1.11 (0.94,1.30) 266.7
Dietary adherence 1.15 (0.99,1.33) − 275.0 1.07 (1.00,1.13) −133.3
Takeaway food consumption 1.07 (1.00,1.15) −75.0 1.06 (1.00,1.13) −100
Full model 1.07 (1.00,1.15) −75.0 1.06 (1.00,1.13) −100
RR relative risk, CI confidence interval, Base model adjusted for: Age, education, duration of follow-up, marital status, self-reported physical health status, history of
cardiometabolic diseases, and use of oral contraceptive (in women), PERM percentage of excess risk explained by the mediator
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We found that the association between baseline BMI
and elevated risk of mood disorder was limited to fe-
males. This is consistent with findings from previous
studies, which have demonstrated a relationship between
BMI and subsequent risk of mood disorder in females
but not in males [52, 53]. A longitudinal study of 4410
participants in the US found that overweight in adoles-
cence was associated with higher odds of developing de-
pressive symptoms (odds ratio:1.74) in later adulthood
in females, but not in males [53]. One possible explan-
ation is that, in women, higher BMI is related with nega-
tive body image perception and satisfaction, which in
turn, is associated with higher risk of mood disorders
[54]. According to previous studies, weight dissatisfac-
tion is both common and has stronger effect on depres-
sion in middle-aged than in younger adults [55, 56].
Our findings on the mediating role of dietary pattern
and health behaviours, for mood disorder and BMI, are
consistent with the common factors associated with both
conditions. Studies suggest that people living with men-
tal health disorders are significantly more likely to en-
gage in low levels of physical activity, more likely to
smoke cigarettes and have poor diet quality [57, 58],
which in turn are known to increase the risk of weight
gain. On the other hand, weight gain increases risk of
declining physical activity and diet quality over time
[59]. Furthermore, increase in body weight has been
shown to activate chronic low-grade inflammation and
low-grade systemic inflammation contributes to the de-
velopment of mental disorders [60, 61]. From a public
health point of view, the mediating effect of physical ac-
tivity and dietary patterns on the risk of BMI and mood
disorder suggest that interventions targeting these risk
factors may not only promote physical health but also
improve mental health.
Association between BMI and anxiety
The finding that history of anxiety was not associated
with subsequent changes in BMI and vice-versa, is con-
sistent with reports from previous studies [62–64], al-
though positive associations have also been reported [38,
65, 66]. The reasons why previous studies have been in-
consistent regarding the association between anxiety and
change in BMI are not clear. One possible explanation
could be the heterogeneity among the studies in terms
of duration of follow-up, participant characteristics, and
confounding variables. One previous study suggest that
the association between depression and weight gain in-
creases with increasing duration of follow-up, which
could also be the case for anxiety [21]. Some of the stud-
ies that reported a positive association between weight
or BMI and anxiety had longer duration of follow-up
(up to 10 to 20 years) [38, 65]. Race may also play a role
in the association between anxiety and weight gain. A
population-based study among 103,557 residents of
Olmsted County, Minnesota found that anxiety was sig-
nificantly associated with obesity in Blacks but not in
Asian or Hispanic groups [67]. However, data on race
was not collected in our study, however, the majority of
participants in the current study were Caucasian.
This study has some limitations. First, there was a sub-
stantial loss to follow-up from the original ASHFS random
sample to the analysis sample. Study participants included
in the present analyses were more likely to be employed,
educated beyond high school, and have a healthier lifestyle
[28]. However, inverse probability weighting, including
variables that predicted non-response, was applied to
minimize the effect of selection bias due to loss to follow-
up. Participants were young-adults, and application of the
findings to older populations in the community may be
limited. Due to self-reporting, some misclassification of
anxiety or mood disorder and under or over estimation of
body weight is inevitable. However, both misclassification
and under or over reporting are probably non-differential
across the different study outcomes. Controlling for the
confounding effect in the analyses may not entirely re-
move the confounding effect of some variables, such as
diet and physical activity, which might have been mea-
sured without sufficient accuracy. Adjusting for change in
predictor variables from baseline to follow-up may have
potentially introduced reverse causation bias. However,
the conclusions were consistent when the outcomes were
BMI recorded at last follow-up and anxiety and mood dis-
order in the last 12months. Furthermore, the multiple-
testing issue may also be a limitation of this study. A sub-
stantial proportion of the participants were overweight or
obese at baseline [33], which might have underestimated
the change in BMI attributed to anxiety or mood disor-
ders. Although correction for self-reporting error has been
applied, the use of self-reported height and weight in some
participants may have resulted in under-reporting of BMI.
Strengths of this study include its well-characterized
cohort of younger adults, its use of adequate sample size,
and its exploration of the mediation and confounding ef-
fect of a wide range of variables. Both lifestyle-related
risk factors, and anxiety and mood disorders were mea-
sured using standardised data collection tools commonly
used for epidemiological studies. The fact that the par-
ticipants were younger individuals means that the find-
ings are less likely to be confounded by chronic
conditions. The findings were consistent when the ana-
lyses were restricted to those who have recent episode of
anxiety or mood disorders.
Conclusions
In a cohort of young adults, mood disorder before base-
line is associated with elevated BMI in males, while base-
line BMI increased the risk of developing mood disorder
Sahle et al. BMC Psychiatry          (2019) 19:398 Page 9 of 12
only in females. These associations were mediated by
dietary pattern and lifestyle factors, suggesting that inter-
ventions promoting healthy lifestyle could contribute to
reducing increase in BMI associated with mood disorder
in males, and excess risk of mood disorder associated
with BMI in females. There was no significant associ-
ation between history of anxiety and subsequent change
in BMI or vice versa in both males and females.
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